Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Caspases and neuroprotection.

James Bilsland1, Sarah Harper

  • 1Department of Biochemistry and Molecular Biology, Merck, Sharp and Dohme Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex, CM20 2QR, UK. james_bilsland@merck.com

Current Opinion in Investigational Drugs (London, England : 2000)
|January 17, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The go-along method with older adults: A transformative approach to participatory research on aging.

Journal of aging studies·2026
Same author

SIREN 2025 National Research Meeting: Advancing the Science of Social Care.

Health services research·2025
Same author

Illuminating the multidimensional contributions of small-scale fisheries.

Nature·2025
Same author

Functional Transitions Among Older Adults in Rural China: Examining the Differential Roles of Care From Daughters' and Sons' Families.

The journals of gerontology. Series B, Psychological sciences and social sciences·2024
Same author

Are all fibrinogen concentrates the same? The effects of two fibrinogen therapies in an afibrinogenemic patient and in a fibrinogen deficient plasma model. A clinical and laboratory case report.

Frontiers in medicine·2024
Same author

Community-based person-centred integrated care (PIC) networks for healthy ageing in place: a scoping review protocol.

BMJ open·2024

Caspase inhibition shows neuroprotective effects in models of Parkinson's disease and cerebral ischemia. However, improved inhibitors are needed for better long-term functional recovery in neurodegenerative disorders.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Apoptotic cell death contributes to neurodegenerative diseases.
  • Caspase proteases are key mediators of apoptosis.
  • Current caspase inhibitors offer limited functional recovery.

Purpose of the Study:

  • To review the neuroprotective role of caspase inhibition.
  • To evaluate evidence in Parkinson's disease and cerebral ischemia models.

Main Methods:

  • Literature review of in vivo and in vitro studies.
  • Critical evaluation of caspase inhibition efficacy.
  • Analysis of neuroprotection versus functional recovery.

Main Results:

  • Caspase inhibition prevents neuronal death in neurodegenerative models.

Related Experiment Videos

  • Neuronal sparing does not always equate to functional recovery.
  • Limitations of current inhibitors impact long-term outcomes.

    • Conclusions:

    • Caspase inhibition is a promising neuroprotective strategy.
    • Further development of caspase inhibitors is crucial for functional recovery.
    • Targeting caspases holds potential for treating neurodegenerative conditions.